Medical research

Using nanobodies to block a tick-borne bacterial infection

Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research ...

Oncology & Cancer

Anti-cancer drug's mode of operation deciphered

Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...

Oncology & Cancer

Novel organoid models illuminate the path to cervical cancers

Organoids are increasingly being used in biomedical research. These are organ-like structures created in the laboratory that are only a few millimeters in size. Organoids can be used to study life processes and the effect ...

page 9 from 40